Discrete T cell populations with specificity for a neo-self-antigen bear distinct imprints of tolerance

Journal of Immunology

Volumn 178, Issue 6, 2007, Pages 3544-3550

  Standifer, Nathan E ^a,c   Stacy, Sue ^b   Kraig, Ellen ^a,b   Infante, Anthony J ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE RECEPTOR ALPHA; AUTOANTIGEN; CHOLINERGIC RECEPTOR; EPITOPE; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE; GENE EXPRESSION; GENE SEQUENCE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; QUANTITATIVE ANALYSIS; TCRBV GENE; TCRBV6 GENE; TORPEDO; TRANSGENE; TRANSGENIC MOUSE;

EID: 33947280932     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.6.3544     Document Type: Article

References (29)

1. Liston, A., S. besage, D. H. Gray, R. L. Boyd, and C. C. Goodnow. 2005. Genetic lesions in T-cell tolerance and thresholds for autoimmunity. Immunol. Rev. 204: 87-101.
2. Goodnow, C. C., J. Sprent, B. Fazekas de St. Groth, and C. G. Vinuesa. 2005. Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435: 590-597.
3. Macian, F., S. H. Im, F. J. Garcia-Cozar, and A. Rao. 2004. T-cell anergy. Curr. Opin. Immunol. 16: 209-216.
4. Miller, J. F., and R. A. Flavell. 1994. T-cell tolerance and autoimmunity in transgenic models of central and peripheral tolerance. Curr. Opin. Immunol. 6: 892-899.
5. Ridgway, W., M. Fasso, and C. G. Fathman. 1998. Following antigen challenge, T cells up-regulate cell surface expression of CD4 in vitro and in vivo. J. Immunol. 161: 714-720.
6. high expression as a marker. J. Immunol. 163: 5708-5714.
7. Christadoss, P., M. Poussin, and C. Deng. 2000. Animal models of myasthenia gravis. [Published erratum appears in 2000 Clin. Immunol. 95: 170]. Clin. Immunol. 94: 75-87.
8. Stacy, S., B. E. Gelb, B. A. Koop, J. J. Windle, K. A. Wall, K. A. Krolick, A. J. Infante, and E. Kraig. 2002. Split tolerance in a novel transgenic model of autoimmune myasthenia gravis. J. Immunol. 169: 6570-6579.
9. Wall, K. A., J. Y. Hu, P. Currier, S. Southwood, A. Sette, and A. J. Infante. 1994. A disease-related epitope of Torpedo acetylcholine receptor: residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. J. Immunol. 152: 4526-4536.
10. Pierce, J. L., K. A. Zborowski, E. Kraig, and A. J. Infante. 1994. Highly conserved TCR β chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis. Int. Immunol. 6: 775-783.
11. Kraig, E., J. L. Pierce, K. Z. Clarkin, N. E. Standifer, P. Currier, K. A. Wall, and A. J. Infante. 1996. Restricted T cell receptor repertoire for acetylcholine receptor in murine myasthenia gravis. J. Neuroimmunol. 71: 87-95.
12. Yang, B., K. R. McIntosh, and D. B. Drachman. 1998. How subtle differences in MHC class II affect the severity of experimental myasthenia gravis. Clin. Immunol. Immunopathol. 86: 45-58.
13. Infante, A. J., and E. Kraig. 1999. Myasthenia gravis and its animal model: T cell receptor expression in an antibody mediated autoimmune disease. Int. Rev. Immunol. 18: 83-109.
14. Standifer, N. E., E. Kraig, and A. J. Infante. 2003. A hierarchy of T cell receptor motifs determines responsiveness to the immunodominant epitope in experimental autoimmune myasthenia gravis. J. Neuroimmunol. 145: 68-76.
15. Wu, B., M. Shenoy, E. Goluszko, R. Kaul, and P. Christadoss. 1995. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis: usage of multiple TCRBV genes in the H-2b strains. J. Immunol. 154: 3603-3610.
16. Tzartos, S. J., A. Kokla, S. L. Walgrave, and B. M. Conti-Tronconi. 1988. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the α subunit. Proc. Natl. Acad. Sci. USA 85: 2899-2903.
17. Balasa, B., C. Deng, J. Lee, L. M. Bradley, D. K. Dalton, P. Christadoss, and N. Sarvetnick. 1997. Interferon γ (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med. 186: 385-391.
18. Balasa, B., C. Deng, J. Lee, P. Christadoss, and N. Sarvetnick. 1998. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. J. Immunol. 161: 2856-2862.
19. Karachunski, P. I., N. S. Ostlie, C. Monfardini, and B. M. Conti-Fine. 2000. Absence of IFN-γ or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice. J. Immunol. 164: 5236-5244.
20. Moiola, L., F. Galbiati, G. Martino, S. Amadio, E. Brambilla, G. Comi, A. Vincent, L. M. Grimaldi, and L. Adorini. 1998. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur. J. Immunol. 28: 2487-2497.
21. Ostlie, N., M. Milani, W. Wang, D. Okita, and B. M. Conti-Fine. 2003. Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice. J. Immunol. 170: 604-612.
22. Sitaraman, S., D. W. Metzger, R. J. Bellow, A. J. Infante, and K. A. Wall. 2000. Interleukin-12 enhances clinical experimental autoimmune myasthenia gravis in susceptible but not resistant mice. J. Neuroimmunol. 107: 73-82.
23. Wang, H. B., F. D. Shi, H. Li, P. H. van der Meide, H. G. Ljunggren, and H. Link. 2000. Role for interferon-γ in rat strains with different susceptibility to experimental autoimmune myasthenia gravis. Clin. Immunol. 95: 156-162.
24. Zhang, G. X., B. G. Xiao, X. F. Bai, A. Orn, P. H. van der Meide, and H. Link. 1998. IFN-γ is required to induce experimental autoimmune myasthenia gravis. Ann. NY Acad. Sci. 841: 576-579.
25. Zhang, G. X., B. G. Xiao, X. F. Bai, P. H. van der Meide, A. Orn, and H. Link. 1999. Mice with IFN-γ receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. J. Immunol. 162: 3775-3781.
26. Bouneaud, C., P. Kourilsky, and P. Bousso. 2000. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13: 829-840.
27. Salmon, A. M., C. Bruand, A. Cardona, J. P. Changeux, and S. Berrih-Aknin. 1998. An acetylcholine receptor α subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis. J. Clin. Invest. 101: 2340-2350.
28. Akkaraju, S., W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, and C. C. Goodnow. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7: 255-271.
29. + regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J. Immunol. 173: 236-244.